STAAR SURGICAL CO — Director's Dealing 2020

Nov 12, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: STAAR SURGICAL CO (STAA)
CIK: 0000718937
Period of Report: 2020-11-09

Reporting Person: Hayashida Jon K. (VP, Global Clinical, Medical)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-11-09	Common Stock	M	10200	$29.80	Acquired	20994	Direct
2020-11-09	Common Stock	M	9800	$16.15	Acquired	30794	Direct
2020-11-09	Common Stock	S	20000	$81.34	Disposed	10794	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-11-09	Common Stock Options	$29.80	M	10200	Disposed	2028-06-13	Common Stock (10200)	Direct
2020-11-09	Common Stock Options	$16.15	M	9800	Disposed	2028-03-14	Common Stock (9800)	Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.06 to $82.85, inclusive.